Immune phenotype of peripheral blood mononuclear cells in patients with high-risk non-muscle invasive bladder cancer

被引：0
|
作者：
François Audenet
Adam M. Farkas
Harry Anastos
Matthew D. Galsky
Nina Bhardwaj
John P. Sfakianos
机构：
[1] Icahn School of Medicine at Mount Sinai,Department of Urology
[2] Icahn School of Medicine at Mount Sinai,Division of Hematology and Oncology, Department of Medicine, Tisch Cancer Institute
来源：
World Journal of Urology | 2018年 / 36卷
关键词：
BCG; Immune checkpoints; Immune phenotype; Non-muscle invasive bladder cancer; Peripheral blood mononuclear cells; Predictive factors;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1741 / 1748
页数：7
相关论文
共 50 条
  • [1] Immune phenotype of peripheral blood mononuclear cells in patients with high-risk non-muscle invasive bladder cancer
    Audenet, Francois
    Farkas, Adam M.
    Anastos, Harry
    Galsky, Matthew D.
    Bhardwaj, Nina
    Sfakianos, John P.
    WORLD JOURNAL OF UROLOGY, 2018, 36 (11) : 1741 - 1748
  • [2] Management of high-risk non-muscle invasive bladder cancer
    Brausi, M.
    Olaru, V.
    MINERVA UROLOGICA E NEFROLOGICA, 2012, 64 (04) : 255 - 260
  • [3] THE OUTCOME OF PATIENTS WITH HIGH-RISK NON-MUSCLE INVASIVE BLADDER CANCER IN SWEDEN
    Wang, Eugen
    Larsson, Ulf
    Gardmark, Truls
    Malmstrom, Per-Uno
    JOURNAL OF UROLOGY, 2020, 203 : E1077 - E1077
  • [4] The Promise of Radiotherapy in High-Risk Non-Muscle Invasive Bladder Cancer
    Bola, Becky
    Hoskin, Peter J.
    Sangar, Vijay
    Choudhury, Ananya
    CANCERS, 2025, 17 (04)
  • [5] Genomic characterization of high-risk non-muscle invasive bladder cancer
    Meeks, Joshua J.
    Carneiro, Benedito A.
    Pai, Sachin G.
    Oberlin, Daniel T.
    Rademaker, Alfred
    Fedorchak, Kyle
    Balasubramanian, Sohail
    Elvin, Julia
    Beaubier, Nike
    Giles, Francis J.
    ONCOTARGET, 2016, 7 (46) : 75176 - 75184
  • [6] Pembrolizumab monotherapy for high-risk, non-muscle invasive bladder cancer
    Balar, Arjun, V
    Kamat, Ashish M.
    de Wit, Ronald
    LANCET ONCOLOGY, 2021, 22 (09): : E380 - E380
  • [7] Novel Therapies for High-Risk Non-Muscle Invasive Bladder Cancer
    Bashir Al Hussein Al Awamlh
    Sam S. Chang
    Current Oncology Reports, 2023, 25 : 83 - 91
  • [8] Novel Therapies for High-Risk Non-Muscle Invasive Bladder Cancer
    Al Awamlh, Bashir Al Hussein
    Chang, Sam S.
    CURRENT ONCOLOGY REPORTS, 2023, 25 (02) : 83 - 91
  • [9] Chromosomal imbalance in the progression of high-risk non-muscle invasive bladder cancer
    Zieger, Karsten
    Wiuf, Carsten
    Jensen, Klaus Moller-Ernst
    Orntoft, Torben Falck
    Dyrskjot, Lars
    BMC CANCER, 2009, 9
  • [10] Chromosomal imbalance in the progression of high-risk non-muscle invasive bladder cancer
    Karsten Zieger
    Carsten Wiuf
    Klaus Møller-Ernst Jensen
    Torben Falck Ørntoft
    Lars Dyrskjøt
    BMC Cancer, 9 (1)
12345